Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Afsendt

Surgical resection of glioblastomas induces pleiotrophin-mediated self-renewal of glioblastoma stem cells in recurrent tumors

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Efficacy and safety of larotrectinib in TRK fusion-positive primary central nervous system tumors

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Diagnostic Accuracy and Clinical Impact of [ 18F]FET PET in Childhood CNS tumors

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Establishing anchor-based minimally important differences for the EORTC QLQ-C30 in glioma patients

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Partitioned glioma heritability shows subtype-specific enrichment in immune cells

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Letter to the Editor. Copenhagen grading of meningioma

    Publikation: Bidrag til tidsskriftLetterForskningpeer review

  2. Implementation of TERT promoter mutations improve prognostication of the WHO classification in meningioma

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Expression, prognostic significance and therapeutic implications of PD-L1 in gliomas

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  4. Fluorescein-guided resection of cerebral metastases is associated with greater tumor resection

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • Arnon Møldrup Knudsen
  • Bo Halle
  • Oriane Cédile
  • Mark Burton
  • Christina Baun
  • Helge Thisgaard
  • Atul Anand
  • Christopher Hubert
  • Mads Thomassen
  • Signe Regner Michaelsen
  • Birgitte Brinkmann Olsen
  • Rikke Hedegaard Dahlrot
  • Rolf Bjerkvig
  • Justin Durla Lathia
  • Bjarne Winther Kristensen
Vis graf over relationer

BACKGROUND: Glioblastomas are highly resistant to therapy, and virtually all patients experience tumor recurrence after standard-of-care treatment. Surgical tumor resection is a cornerstone in glioblastoma therapy, but its impact on cellular phenotypes in the local post-surgical microenvironment has yet to be fully elucidated.

METHODS: We developed a preclinical orthotopic xenograft tumor resection model in rats with integrated 18F-FET PET/CT imaging. Primary and recurrent tumors were subject to bulk and single cell RNA sequencing. Differentially expressed genes and pathways were investigated and validated using tissue specimens from the xenograft model, 23 patients with matched primary/recurrent tumors, and a cohort including 190 glioblastoma patients. Functional investigations were performed in vitro with multiple patient-derived cell cultures.

RESULTS: Tumor resection induced microglia/macrophage infiltration, angiogenesis as well as proliferation and upregulation of several stem cell related genes in recurrent tumor cells. Expression changes of selected genes SOX2, POU3F2, OLIG2 and NOTCH1 were validated at the protein level in xenografts and early recurrent patient tumors. Single cell transcriptomics revealed presence of distinct phenotypic cell clusters in recurrent tumors which deviated from clusters found in primary tumors. Recurrent tumors expressed elevated levels of pleiotrophin (PTN), secreted by both tumor cells and tumor-associated microglia/macrophages. Mechanistically, PTN could induce tumor cell proliferation, self-renewal and the stem cell program. In glioblastoma patients, high PTN expression was associated with poor overall survival, and identified as an independent prognostic factor.

CONCLUSION: Surgical tumor resection is an iatrogenic driver of PTN-mediated self-renewal in glioblastoma tumor cells that promotes therapeutic resistance and tumor recurrence.

OriginalsprogEngelsk
TidsskriftNeuro-Oncology
ISSN1522-8517
DOI
StatusAfsendt - 29 dec. 2021

Bibliografisk note

© The Author(s) 2021. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

ID: 71673272